Skip to content
GuerillaStockTrading
  • Latest News
    • Analysts Activity
    • Biotechnology
    • Dark Pool Trading
    • Coronavirus
    • Options Trading
  • SIGN UP FOR PREMIUM CONTENT
  • Saturday Shows
  • Log In
  • Trading Tools
  • Lessons
  • Contact
  • About
  • Close Search Form
    Open Search Form
Tag

Therapy

GuerillaStockTrading
Stocks To Watch
October 22, 2017

Verastem Inc Price Target Raised By Cantor Fitzgerald

Verastem Inc price target was raised to $17 by Cantor Fitzgerald last week. The new $17 price target represents 330% upside from the previous close of $3.95. Cantor has a
Global Blood Therapeutics stock looks strong with rising large players volume.
Stocks To Watch
October 19, 2017

Global Blood Therapeutics Rising Large Players Volume

Global Blood Therapeutics stock has excellent large players volume action. Large players volume is in an uptrend and is confirmed by the rising Twiggs Money Flow. Global Blood Therapeutics stock has
Stocks To Watch
May 7, 2017

Sell Immunogen For an Incredible 101% Win

May 7, 2017: Sell Immunogen for a 101% win in 85 days and congratulations if you made money on the trade. April 19, 2017: Immunogen's stock popped 13% today on
Stocks To Watch
April 30, 2017

Sell Anavex Life Sciences For a Huge 40% Win

April 30, 2017: Sell Anavex Life Sciences for a huge 40% win and congratulations if you made money on this trade. January 8, 2017: Institutional traders are accumulating biotechnology firm
GuerillaStockTrading
Stocks To Watch
April 16, 2017

Sell Catalyst Pharmaceuticals For a 47% Gain

April 16, 2017: Sell Catalyst Pharmaceuticals for a 47% gain in 60 days and congratulations if you made money on the trade. January 4, 2017: The popular SeekingAlpha blogger Hawkinvest, with
GuerillaStockTrading
Stocks To Watch
March 4, 2017

Sell Global Blood Therapeutics For a Huge 91% Win!

March 4, 2017: Sell Global Blood Therapeutics for a monster 91% win in 41 days! Congratulations if you were able to make money on the trade. January 4, 2017: JPMorgan
GuerillaStockTrading
Stocks To Watch
February 23, 2017

Wells Fargo Gives Buy On Juno One Day, Downgrades the Next!

February 23, 2017: Wells Fargo initiated coverage of JUNO on February 22, 2017 with an Outperform rating. Then, one day later on February 23, 2017, Wells Fargo downgraded JUNO to
  • Sign Up For Premium Content
  • Log In

Trending News

  • Coronavirus
    COVID-19 Bombshell Revealed: Fauci Said Hydroxychloroquine Was Cure To COVID In 2005
  • US Economy
    Great Reset Rolling Out At Davos Agenda On January 26 2021
  • Biotechnology
    $IBIO iBio Stock Surges 16% In After-hours
  • Stock Trading
    $LAC Lithium Americas Surges On Decision for Thacker Pass
  • Options Trading
    $GSAT Globalstar Stock Bullish Option Flow
  • Technology
    $CRNT Ceragon Networks Bullish Option Flow Detected
  • Biotechnology
    $GILD Gilead Sciences Stock Up On Morgan Stanley Upgrade
  • Biotechnology
    $ADMP Adamis Pharmaceuticals Up In After-hours Trade

Pages

  • As Seen On
  • Economics of the Media Certification
  • Glossary
  • International Trade Certification
  • Macroeconomics Certification
  • Microeconomics Certification
  • The Eurozone Crisis Certification
  • TSAA-SF Certification

Disclaimer: We are not licensed advisors or registered financial consultants. Alerts should not be considered as recommendations or solicitations to buy or sell any security. You assume complete responsibility for your own trades and investments. The market is volatile, and trades and investments can result in total loss of capital. We assume no responsibility for any losses. We may have positions in some stocks that are mentioned and we will disclose that when an article is published. We may liquidate these positions at any time without notification. Past results are not necessarily indicative of future performance. Any trades or investments are committed at your own risk. The opinions posted here are intended for educational purpose only.

GuerillaStockTrading

©2009-2020 GuerillaStockTrading.com. All Rights Reserved. Terms of Use | Privacy Policy